DOI:
10.1055/s-00000020
Geburtshilfe und Frauenheilkunde
LinksClose Window
References
Olson EM, Lin NU, DiPiro PJ. et al.
Responses to subsequent anti-HER2 therapy after treatment with trastuzumab-DM1 in women with HER2-positive metastatic breast cancer.
Ann Oncol 2012;
23: 93-97
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.